Induced abortion as cancer risk factor: a review of epidemiological evidence Larissa I Remennick In spite of the fact that efficient contraception is available in many countries, induced abortion is still a quite prevalent means of birth control, especially in certain subpopulations of women (young, socially deprived, etc). Judging by the published statistics, induced abortion rates vary dramatically between countries, with the lowest level being in West Germany (5-7 per 1000 women aged and the highest in the Russian Federation of the USSR (123-6 in the mid-80s2).
Ever since its legalisation in 1955, induced abortion has been the primary means to reduce fertility in the USSR, resulting in 7 116 000 terminations in this country in 1986 (compared with only about 5 611 000 livebirths2), or 101 2 per 1000 women of reproductive age. 2 The real prevalence of induced abortion in the USSR is even higher than reflected by official statistics, since there is substantial underreporting in many areas, especially for the youngest and primigravid women. 3 Results of a few surveys suggest that on average a sexually active woman has 2-4 induced abortions by the end of her reproductive period, and roughly 10-15% of the women have their first pregnancy interrupted.3 Induced abortion rates are highly differentiated between national, regional, and social subgroups of the population. Thus the range of variation between the national republics in registered induced abortion rates in 1985 was fourfold, ie, 30-8% in Azerbaidjan versus 123-6% in the Russian Federation. 2 Sociodemographic and public health implications of multiple induced abortion in the USSR are well known: fertility reduction due to secondary postabortive sterility/subfecundity, high prevalence of chronic gynaecological conditions in young and middle aged women, obstetric complications, and high infant mortality.5 But up to now, clinical (and a few epidemiological) investigations have been focused on immediate and short term complications of induced abortion and its influence on subsequent reproductive function,5 while the long term cumulative effect of pregnancy termination has hardly been assessed. The issue of possible oncological implications of induced abortion discussed in this paper has traditionally been "no man's land" in a highly specialised medical science, as it has been missing from the curriculum of both oncologists and gynaecologists. Epidemiologically Cervical cancer Several studies have suggested a positive association between induced abortion and cancer of the cervix. 23 31-38 Thus a case-control study in Paris and seven other French cities23 has shown an almost fivefold increase in relative risk for women reporting two or more terminations (after adjustment for sexual and other significant variables). In the case-control study in Chile, the country with endemic cervical cancer rates, women with both induced and spontaneous abortion had significantly increased risk, although for spontaneous abortion it was somewhat higher (1- 94 v 1-38) . 32 Descriptive epidemiological studies in the USSR393 have suggested that regional variance in cervical cancer incidence is related more to induced abortion than to fertility rates. Thus the majority of cervical cancers in Armenia 42 It has also been shown that dysplasias and intraepithelial neoplasms of the cervix are more prevalent in women with the history of induced abortion.32 35 42 Ovarian There are rational arguments for both approaches, but the second seems more plausible biologically and is also backed up by certain clinical and experimental data.
The role of induced abortion in female cancers obviously needs further scrutiny, preferably in analytical studies specially addressing this issue and in populations with high induced abortion rates (so far all but a few studies have been conducted in the countries with low/moderate induced abortion rates). One of the questions to be clarified is the suggested cross over effect in the action of pregnancy related risk factors for breast cancer.8 15 
